Adaptive Biotechnologies Corp (ADPT) poses a Brand-New Opportunity for Investors with beta value of 1.71
Adaptive Biotechnologies Corp (NASDAQ: ADPT) remained unchanged at $8.81, as the Stock market unbolted on Wednesday, before settling in for the price of $8.81 at